Thiotepa Injection, Powder, Lyophilized, For Solution
Product Images NDC 65219-029

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Thiotepa (NDC 65219-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Thi07 0000 01)

FDA Label Image

Fresenius Kabi Logo (Thi07 0000 02)

FDA Label Image

Package Label – Principal Display Panel – 100 mg – Vial Label (Thi07 0000 03)

Package Label – Principal Display Panel – 100 mg – Vial Label (Thi07 0000 03)
Thiotepa is a cytotoxic agent manufactured for Fresenius Kabi. It comes in a single dose vial for intravenous, intracavitary, or intravesical use. The NDC number is 65219-029-20 and it is available by prescription only. The drug is used to treat cancer.*
FDA Label Image

Package Label – Principal Display Panel – 100 mg – Individual Carton (Thi07 0000 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.